Clinical Trial Update: Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating short-course radiotherapy followed by tislelizumab combined with CapeOX for locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: COMPLETED